MyOme pricing
MyOme's site offers routes for patients, providers, employers and health systems, and names a Collective Health partnership for employers, without a price, unit of charge or insurance position. The breast cancer score supplied with Natera's Empower test and the Natera Zenith tests are sold by Natera on its own terms.
How MyOme pricing works
- Pricing model
- Whole genome screening tests ordered through clinicians and sold to employers, benefits consultants and health systems; no unit of charge published.
- Business associate agreement
- Covered entity for results it reports; customer data governed by business associate agreements, which are not published.
MyOme pricing against its alternatives
Published prices for MyOme and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- MMyOmeNo published price
- AAllelicaNo published price
- AAmbry GeneticsNot published; 9 in 10 patients pay $0
- MMyriad GeneticsMost eligible patients pay $0; financial assistance tiers of $0, $100 or $249
- GGenomicsNo published price
- HHelixNo published price
- GGeneDxNo published price
- IInvitaeNo published price
- BBostonGeneNo published price
MyOme pricing, answered
How much does MyOme cost?
MyOme does not publish a price. MyOme's site offers routes for patients, providers, employers and health systems, and names a Collective Health partnership for employers, without a price, unit of charge or insurance position. The breast cancer score supplied with Natera's Empower test and the Natera Zenith tests are sold by Natera on its own terms.
Does MyOme offer a business associate agreement?
Covered entity for results it reports; customer data governed by business associate agreements, which are not published.